The Dow Jones and S&P 500 held onto gains. Nvidia sank below a moving average while medical test stocks breaks out.

Sentiment surrounding AMD (NASDAQ:AMD) ahead of its upcoming Q4 2024 earnings release suggests a below consensus guide for Q2 2025 is already priced into the stock, according to Wells Fargo.

With the chipmaker due to report fourth-quarter results on Feb. 4, AMD stock looks like it's a buy, no matter what earnings say. Wall Street forecasts Advanced Micro Devices will report revenue of ...

AMD is undervalued, but competition and macro risks limit upside. Find out why AMD stock won’t aggressively rebound in the ...

With Advanced Micro Devices offering mixed signals ahead of its Q4 earnings, a directionally neutral strategy may be best for ...

Friday, Feb. 7 8:30 a.m.: Canada employment report (January), U.S. employment report (January) ...

On Tuesday, the Nasdaq and S&P finished lower while the Dow gained 0.5%. AMD posted better-than-expected earnings and raised its forecast on the back of investments in artificial intelligence.

Investors fretted about the potential for an earnings-related selloff in Nvidia shares headed into the quarter. They're now breathing a sigh of relief. Nvidia shares have jumped 7.7% in late ...

AMD is under heavy pressure to defend its stock-market valuation This article is part of a series where tech-company analyst Ryan Shrout evaluates tech-industry leaders' prospects for 2025. Some ...

Sentiment surrounding AMD (NASDAQ:AMD) ahead of its upcoming Q4 2024 earnings release suggests a below consensus guide for Q2 2025 is already priced into the stock, according to Wells Fargo. Warning!